Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Magnetic Resonance Imaging With Hyperpolarized Pyruvate (13C) In Patients With Fatty Liver Disease

NCT06176079 is registered in ClinicalTrials.gov with Michael Ohliger, MD PhD as lead sponsor.

NCT NCT06176079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Magnetic Resonance Imaging With Hyperpolarized Pyruvate (13C) In Patients With Fatty Liver Disease
Lead sponsor
Michael Ohliger, MD PhD
Phase
Observational
Overall status
Completed
Start date
July 22, 2020
Completion date
August 28, 2025
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, nash, non alcoholic fatty liver, non alcoholic steatohepatitis, non-alcoholic fatty liver disease